Skip to main content
. 2021 Apr 12;95(9):e02165-20. doi: 10.1128/JVI.02165-20

FIG 1.

FIG 1

Trial design. (A) Schematics of study design. Blue arrows indicate time of DNA GTU-MultiHIV B or placebo administrations. Red arrows indicate time of HIV LIPO-5 or placebo administrations. ART, antiretroviral therapy; ATI, analytical treatment interruption; (B) Consolidated Standards of Reporting Trials (CONSORT) flow diagram for the trial. CONSORT diagram delineates the study enrollment of 103 participants who underwent randomization to the placebo or vaccine groups.